You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
佐力藥業(300181.SZ):靈蓮花顆粒沒有進入國家醫保,公司已經將其轉為OTC品種
格隆匯 02-01 15:29

格隆匯2月1日丨佐力藥業(300181.SZ)於近期接受投資者調研,就“公司對靈蓮花顆粒有何規劃?”,公司回覆稱,靈蓮花顆粒屬於公司烏靈系列產品,是在中醫藥理論指導下圍繞烏靈菌粉延伸開發的複方製劑,致力於綜合改善女性更年期症狀,更好關注更年期女性的情緒及睡眠,臨牀上治療效果明顯,已經進入《中成藥治療更年期綜合徵臨牀應用指南》的強推薦品種。靈蓮花顆粒沒有進入國家醫保,公司已經將其轉為OTC品種,目前處於公示期,該產品的營銷方案也已經在策劃,今後將通過院外端不斷髮力,提升產品銷售量。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account